Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joke Bilcke

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Medical Decision Making : an International Journal of the Society for Medical Decision Making|June 10, 2011
Accounting for methodological, structural, and parameter uncertainty in decision-analytic models: a practical guideJoke Bilcke, Philippe Beutels, Marc Brisson, et al.
Archives of Public Health = Archives Belges De Sante Publique|November 14, 2025
Identifying indicators of "success" in managing the COVID-19 pandemic in Europe: insights from an interdisciplinary expert consultationZhuxin Mao, Zita Zsabokorszky, Joke Bilcke, et al.
The Lancet. Infectious Diseases|February 27, 2021
Strategies for typhoid conjugate vaccines in endemic nations - Authors' replyVirginia E Pitzer, Andrew J Pollard, Joke Bilcke
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 24, 2026
Estimating EQ-5D-5L quality-adjusted life year weights from GHQ-12 mental health data: a large sample exploration of four mapping methodsZhuxin Mao, Joke Bilcke, Koen Pepermans, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 18, 2014
Cost-effectiveness of socioeconomic support as part of HIV care for the poor in an urban community-based antiretroviral program in UgandaAlamo Stella-Talisuna, Joke Bilcke, Robert Colebunders, et al.
Vaccine|May 22, 2017
Cost-effectiveness analysis of typhoid conjugate vaccines in five endemic low- and middle-income settingsMarina Antillón, Joke Bilcke, A David Paltiel, et al.
Epidemics|April 17, 2025
Optimizing influenza vaccine allocation by age using cost-effectiveness analysis: A comparison of 6720 vaccination program scenarios in children and adults in BelgiumRegina Manansala, Joke Bilcke, Lander Willem, et al.
BMC Infectious Diseases|September 13, 2017
Lessons from a decade of individual-based models for infectious disease transmission: a systematic review (2006-2015)Lander Willem, Frederik Verelst, Joke Bilcke, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 7, 2020
A Computationally Efficient Method for Probabilistic Parameter Threshold Analysis for Health Economic EvaluationsZoë Pieters, Mark Strong, Virginia E Pitzer, et al.
Vaccine|November 29, 2011
Cost-effectiveness of vaccination against herpes zoster in adults aged over 60 years in BelgiumJoke Bilcke, Christiaan Marais, Benson Ogunjimi, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Medical Decision Making : an International Journal of the Society for Medical Decision Making|June 10, 2011
Accounting for methodological, structural, and parameter uncertainty in decision-analytic models: a practical guideJoke Bilcke, Philippe Beutels, Marc Brisson, et al.
Archives of Public Health = Archives Belges De Sante Publique|November 14, 2025
Identifying indicators of "success" in managing the COVID-19 pandemic in Europe: insights from an interdisciplinary expert consultationZhuxin Mao, Zita Zsabokorszky, Joke Bilcke, et al.
The Lancet. Infectious Diseases|February 27, 2021
Strategies for typhoid conjugate vaccines in endemic nations - Authors' replyVirginia E Pitzer, Andrew J Pollard, Joke Bilcke
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 24, 2026
Estimating EQ-5D-5L quality-adjusted life year weights from GHQ-12 mental health data: a large sample exploration of four mapping methodsZhuxin Mao, Joke Bilcke, Koen Pepermans, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 18, 2014
Cost-effectiveness of socioeconomic support as part of HIV care for the poor in an urban community-based antiretroviral program in UgandaAlamo Stella-Talisuna, Joke Bilcke, Robert Colebunders, et al.
Vaccine|May 22, 2017
Cost-effectiveness analysis of typhoid conjugate vaccines in five endemic low- and middle-income settingsMarina Antillón, Joke Bilcke, A David Paltiel, et al.
Epidemics|April 17, 2025
Optimizing influenza vaccine allocation by age using cost-effectiveness analysis: A comparison of 6720 vaccination program scenarios in children and adults in BelgiumRegina Manansala, Joke Bilcke, Lander Willem, et al.
BMC Infectious Diseases|September 13, 2017
Lessons from a decade of individual-based models for infectious disease transmission: a systematic review (2006-2015)Lander Willem, Frederik Verelst, Joke Bilcke, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 7, 2020
A Computationally Efficient Method for Probabilistic Parameter Threshold Analysis for Health Economic EvaluationsZoë Pieters, Mark Strong, Virginia E Pitzer, et al.
Vaccine|November 29, 2011
Cost-effectiveness of vaccination against herpes zoster in adults aged over 60 years in BelgiumJoke Bilcke, Christiaan Marais, Benson Ogunjimi, et al.
Pageof 6